Ratio Wealth Group’s Sonnet BioTherapeutics SONN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9	Closed	-$6.3K	–	63
2022 Q2	$6.3K	Hold	9	–	–	﹤0.01%	57
2022 Q1	$8.46K	Buy	+9	New	+$8.46K	﹤0.01%	57